1262041

Vaughn, Silverberg and Associates, LLP — FEI 3003724356

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 19, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Austin, TX (United States)